Put rules at the capability boundary: Use policy engines, identity systems, and tool permissions to determine what the agent ...
A critical vm2 Node.js vulnerability (CVE-2026-22709, CVSS 9.8) allows sandbox escape via Promise handler bypass.
A hands-on test compared Visual Studio Code and Google Antigravity on generating and refining a simple dynamic Ticket Desk ...
Daniel Jeremiah reveals his initial prospect rankings for the 2026 NFL Draft. What’s the pecking order at wide receiver, with ...
The Mila artificial intelligence institute in Quebec is raising a US$100-million venture capital fund with plans to invest in more than 55 early-stage AI companies, in partnership with Inovia Capital ...
Node.js released updates fixing a critical DoS flaw caused by async_hooks stack crashes, tracked as CVE-2025-59466, impacting ...
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results